CAMBRIDGE, Mass. and VANCOUVER, British Columbia and BASEL, Switzerland, Oct. 21, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: EDIT), a ...

Vertex Pharmaceuticals dominates the cystic fibrosis market with a promising pipeline and strategic M&A activity. Read why I ...

Evolution has turned out bizarre and baffling creatures, such as walking fish. It only gets weirder from there. Some of these ...

New gene therapies developed using CRISPR gene editing offer the promise of treating or even curing debilitating diseases.

CRISPR-Cas9 is a reprogrammable DNA cutting machine that is being used to edit genomes in many organisms for research purposes. Its primary component, the Cas9 enzyme (orange), cuts genomic DNA ...

Amidst the long-running Cas9 patent battle, Editas Medicine has struck a deal to sell a portion of its future revenue stream ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...

JonesTrading analyst Debanjana Chatterjee has assigned their bullish stance on NTLA stock, giving a Buy rating on October 16. Debanjana ...

Review explores how microRNAs (miRNAs) interact in cancer development, their potential in diagnosis, and innovative ...

10pmol riboEDIT™ tracrRNA和1ug riboEDIT™ Cas9 mRNA，48小时后 riboEDIT™ T7EI Enzyme酶切检测靶位点的剪切效率，候选7个靶基因的剪切条带及编辑效率。如图所示，#1#2表示同一基因不同位点设计的2条crRNA。

A renowned hematology expert from Children's Hospital of Philadelphia (CHOP) has been elected to the National Academy of ...